• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Philogen S.p.A. - Product Pipeline Review - Q4 2010 - Product Image

Philogen S.p.A. - Product Pipeline Review - Q4 2010

  • Published: November 2010
  • 28 pages
  • Global Markets Direct

Philogen S.p.A. – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Philogen S.p.A. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Philogen S.p.A. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Philogen S.p.A. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across READ MORE >



List of Tables
List of Figures
Philogen S.p.A. Snapshot
Philogen S.p.A. Overview
Key Information
Key Facts
Philogen S.p.A. – Research and Development Overview
Key Therapeutic Areas
Philogen S.p.A. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Philogen S.p.A. – Pipeline Products Glance
Philogen S.p.A. – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Philogen S.p.A. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Philogen S.p.A. – Drug Profiles
L19IL2 + Dacarbazine
Product Description
Mechanism of Action
R&D Progress
Darleukin + Gemcitabine
Product Description
Mechanism of Action
R&D Progress
Dekavil + Methotrexate
Product Description
Mechanism of Action
R&D Progress
L19IL2 + Dacarbazine
Product Description
Mechanism of Action
R&D Progress
Teleukin + Doxorubicin
Product Description
Mechanism of Action
R&D Progress
Teleukin + Paclitaxel
Product Description
Mechanism of Action
R&D Progress
Tenarad
Product Description
Mechanism of Action
R&D Progress
Teleukin + Doxorubicin
Product Description
Mechanism of Action
R&D Progress
Philogen S.p.A. – Pipeline Analysis
Philogen S.p.A. – Pipeline Products by Therapeutic Class
Philogen S.p.A. Pipeline Products By Target
Philogen S.p.A. – Pipeline Products by Route of Administration
Philogen S.p.A. – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS